A5004962071- Cancer-related Molecular Pathways
- Virus-based gene therapy research
- Genomic variations and chromosomal abnormalities
- Epigenetics and DNA Methylation
- Amino Acid Enzymes and Metabolism
- Gastrointestinal disorders and treatments
- Zoonotic diseases and public health
- Advanced Algebra and Logic
- Intracranial Aneurysms: Treatment and Complications
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Maternal and Neonatal Healthcare
- Medical and Biological Ozone Research
- Streptococcal Infections and Treatments
- Bacterial biofilms and quorum sensing
- Therapeutic Uses of Natural Elements
- Soft tissue tumor case studies
- Inflammasome and immune disorders
- Bone fractures and treatments
- Pancreatic and Hepatic Oncology Research
- Reconstructive Surgery and Microvascular Techniques
- Virology and Viral Diseases
- Urticaria and Related Conditions
- Injury Epidemiology and Prevention
- Nasolacrimal Duct Obstruction Treatments
- Cancer and Skin Lesions
University of Pennsylvania
2023
Lady Hardinge Medical College
1972-2002
Kalawati Saran Children's Hospital
1982-2001
A simple method of assessment gestational age based on only four characteristics, namely, the anterior vascular capsule lens, plantar creases, breast nodule, and ear firmness, is presented. Critical evaluation by appropriate statistical analyses has shown this to be a useful practical value with 95% confidence limits 11 days. It applicable newborn infants, including sick babies, at any time within first 2 days life.
An abstract is not available for this content so a preview has been provided. Please use the Get access link above information on how to content.
Abstract Li-Fraumeni Syndrome (LFS) is a hereditary cancer predisposition syndrome with up to 90% lifetime risk. Cancer screening, including annual whole-body MRI (WB-MRI), recommended due known survival advantage, detection rate of 7% on initial screening. Intervention and rates subsequent screenings are unknown. Clinical data for pediatric adult patients LFS (n = 182) were reviewed, instances WB-MRI screening interventions based results. For each biopsy secondary imaging, as well...
<div>Abstract<p>Li-Fraumeni Syndrome (LFS) is a hereditary cancer predisposition syndrome with up to 90% lifetime risk. Cancer screening, including annual whole-body MRI (WBMRI), recommended due known survival advantage, detection rate of 7% on initial screening. Intervention and rates subsequent screenings are unknown. Clinical data for pediatric adult LFS patients (n=182) were reviewed, instances WBMRI screening interventions based results. For each biopsy secondary imaging, as...
<div>Abstract<p>Li-Fraumeni Syndrome (LFS) is a hereditary cancer predisposition syndrome with up to 90% lifetime risk. Cancer screening, including annual whole-body MRI (WB-MRI), recommended due known survival advantage, detection rate of 7% on initial screening. Intervention and rates subsequent screenings are unknown. Clinical data for pediatric adult patients LFS (<i>n</i> = 182) were reviewed, instances WB-MRI screening interventions based results. For each...
<div>Abstract<p>Li-Fraumeni Syndrome (LFS) is a hereditary cancer predisposition syndrome with up to 90% lifetime risk. Cancer screening, including annual whole-body MRI (WB-MRI), recommended due known survival advantage, detection rate of 7% on initial screening. Intervention and rates subsequent screenings are unknown. Clinical data for pediatric adult patients LFS (<i>n</i> = 182) were reviewed, instances WB-MRI screening interventions based results. For each...